Antiviral testing/screening

Determination and evaluation of toxicity (CC50) and antiviral activity evaluation of selected candidate compounds, enhanced by combining classical laboratory and software-assisted assays (IC50/EC50).

Resistance tests

Evaluation of the potential emergence and temporal development of viral resistance to the specific drug of your choice.

Proviral testing

VirNext evaluates and characterizes the proviral activities of your compounds and proposes optimized production conditions to maximize virus yield, both in cell, 3D reconstituted human lung tissue and embryonated egg-based systems of production.